Jane Street’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-52,420
| Closed | -$896K | – | 5970 |
|
2025
Q1 | $896K | Sell |
52,420
-453,171
| -90% | -$7.74M | ﹤0.01% | 3193 |
|
2024
Q4 | $12.5M | Buy |
505,591
+181,426
| +56% | +$4.49M | ﹤0.01% | 638 |
|
2024
Q3 | $9.24M | Buy |
324,165
+183,848
| +131% | +$5.24M | ﹤0.01% | 799 |
|
2024
Q2 | $3.7M | Buy |
140,317
+72,712
| +108% | +$1.92M | ﹤0.01% | 2007 |
|
2024
Q1 | $2.18M | Sell |
67,605
-546,736
| -89% | -$17.7M | ﹤0.01% | 2211 |
|
2023
Q4 | $25.9M | Buy |
614,341
+285,829
| +87% | +$12M | 0.01% | 436 |
|
2023
Q3 | $12.6M | Buy |
328,512
+167,466
| +104% | +$6.43M | ﹤0.01% | 687 |
|
2023
Q2 | $3.06M | Buy |
161,046
+63,624
| +65% | +$1.21M | ﹤0.01% | 1951 |
|
2023
Q1 | $1.51M | Sell |
97,422
-221,649
| -69% | -$3.44M | ﹤0.01% | 2358 |
|
2022
Q4 | $5.66M | Buy |
319,071
+302,965
| +1,881% | +$5.38M | ﹤0.01% | 1066 |
|
2022
Q3 | $90K | Buy |
+16,106
| New | +$90K | ﹤0.01% | 4934 |
|
2022
Q2 | – | Sell |
-41,178
| Closed | -$226K | – | 5874 |
|
2022
Q1 | $226K | Buy |
41,178
+9,424
| +30% | +$51.7K | ﹤0.01% | 4608 |
|
2021
Q4 | $270K | Sell |
31,754
-47,002
| -60% | -$400K | ﹤0.01% | 4129 |
|
2021
Q3 | $684K | Sell |
78,756
-38,962
| -33% | -$338K | ﹤0.01% | 3093 |
|
2021
Q2 | $1.24M | Buy |
117,718
+104,172
| +769% | +$1.1M | ﹤0.01% | 2316 |
|
2021
Q1 | $217K | Buy |
+13,546
| New | +$217K | ﹤0.01% | 4214 |
|
2020
Q4 | – | Sell |
-14,713
| Closed | -$518K | – | 4125 |
|
2020
Q3 | $518K | Sell |
14,713
-11,608
| -44% | -$409K | ﹤0.01% | 2407 |
|
2020
Q2 | $640K | Buy |
26,321
+14,331
| +120% | +$348K | ﹤0.01% | 2319 |
|
2020
Q1 | $186K | Buy |
+11,990
| New | +$186K | ﹤0.01% | 2917 |
|